| Year | Detail |
| 1912 |
Fresenius Kabi AG Was founded as pharmaceutical company Dr. E. Fresenius. |
| 1966 |
Fresenius starts to sell dialysis machines and dialyzers . |
| 1974 |
Fresenius starts to manufacture infusion solutions and medical disposables. |
| 1979 |
The first ready-to-use tube feed Fresubin is introduced. |
| 1993 |
Launch of Supportan. |
| 1998 |
Fresenius acquired the international infusion business of Pharmacia & Upjohn (Kabi). |
| 1999 |
Fresenius Kabi is formed by combining Fresenius Group's Pharma division with the business acquired from Pharmacia & Upjohn (Kabi). |
| 2000 |
Fresenius Kabi accelerates its worldwide business expansion by opening up new growth markets in Asia, Africa, Latin America. |
| 2005 |
Acquired Labesfal and Clinico. |
| 2008 |
Expanded its business into oncology drugs with the Dabur Pharma acquisition. |
| 2012 |
Fresenius Kabi acquires the transfusion technology company Fenwal. |
| 2016 |
Fresenius Kabi expands its portfolio to ready-to-administer prefilled syringes. |
| 2017 |
Fresenius Kabi entered the growing biosimilars sector. |
| 2019 |
launched its first biosimilar in Europe. |
| 2022 |
Acquired MedTech innovator Ivenix . |